Literature DB >> 28756711

The potential of obscurin as a therapeutic target in muscle disorders.

Davide Randazzo1, Enrico Pierantozzi2, Daniela Rossi2, Vincenzo Sorrentino2.   

Abstract

INTRODUCTION: Obscurin, a giant protein of striated muscles, is emerging as an important player in a wide range of processes including myofibril assembly and maintenance, muscle protein degradation and intracellular signaling. Accordingly, obscurin participates to the mechanisms by which muscles adapt to physiological requirements or to pathological cues associated with cardiac and skeletal muscle diseases. Areas covered: The structure of the different obscurin isoforms identified so far, their tissue distribution and the most recent findings on obscurin in invertebrates and mammals will be reviewed. We will provide a synopsis of known molecular interactions between obscurin and other proteins and the biological relevance of these interactions for striated muscle function. The involvement of obscurin in protein degradation mechanisms and intracellular signaling will be also discussed along with initial evidence of a role of obscurin in the pathophysiology of human diseases. Expert opinion: Although still much remains to be discovered about the role of obscurin either as a structural component of the sarcomere or as a mediator of signaling pathways within muscle cells, it can be envisioned that this protein represents an interesting novel pharmacological target for the prevention and treatment of cardiac and skeletal muscle diseases.

Entities:  

Keywords:  Mechanotransduction; RhoGEF; cardiomyopathy; intracellular signaling; muscle adaptation; muscle atrophy & hypertrophy; muscular dystrophy; protein kinase

Mesh:

Substances:

Year:  2017        PMID: 28756711     DOI: 10.1080/14728222.2017.1361931

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  6 in total

Review 1.  Unraveling obscurins in heart disease.

Authors:  Alyssa Grogan; Aikaterini Kontrogianni-Konstantopoulos
Journal:  Pflugers Arch       Date:  2018-08-11       Impact factor: 3.657

2.  Molecular determinants of homo- and heteromeric interactions of Junctophilin-1 at triads in adult skeletal muscle fibers.

Authors:  Daniela Rossi; Angela Maria Scarcella; Enea Liguori; Stefania Lorenzini; Enrico Pierantozzi; Candice Kutchukian; Vincent Jacquemond; Mirko Messa; Pietro De Camilli; Vincenzo Sorrentino
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-17       Impact factor: 11.205

Review 3.  Understanding the molecular basis of cardiomyopathy.

Authors:  Marie-Louise Bang; Julius Bogomolovas; Ju Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-11-19       Impact factor: 5.125

Review 4.  Rho GTPases in Skeletal Muscle Development and Homeostasis.

Authors:  Sonia Rodríguez-Fdez; Xosé R Bustelo
Journal:  Cells       Date:  2021-11-02       Impact factor: 6.600

5.  Impaired Intracellular Ca2+ Dynamics, M-Band and Sarcomere Fragility in Skeletal Muscles of Obscurin KO Mice.

Authors:  Enrico Pierantozzi; Péter Szentesi; Cecilia Paolini; Beatrix Dienes; János Fodor; Tamás Oláh; Barbara Colombini; Dilson E Rassier; Egidio Maria Rubino; Stephan Lange; Daniela Rossi; László Csernoch; Maria Angela Bagni; Carlo Reggiani; Vincenzo Sorrentino
Journal:  Int J Mol Sci       Date:  2022-01-24       Impact factor: 5.923

6.  A novel FLNC frameshift and an OBSCN variant in a family with distal muscular dystrophy.

Authors:  Daniela Rossi; Johanna Palmio; Anni Evilä; Lucia Galli; Virginia Barone; Tracy A Caldwell; Rachel A Policke; Esraa Aldkheil; Christopher E Berndsen; Nathan T Wright; Edoardo Malfatti; Guy Brochier; Enrico Pierantozzi; Albena Jordanova; Velina Guergueltcheva; Norma Beatriz Romero; Peter Hackman; Bruno Eymard; Bjarne Udd; Vincenzo Sorrentino
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.